EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

CUSIP: 30068X103

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
23,444,245
Total 13F shares
9,090,221
Share change
+487,158
Total reported value
$72,994,000
Price per share
$8.03
Number of holders
53
Value change
+$3,569,328
Number of buys
22
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 30068X103?
CUSIP 30068X103 identifies XGN - EXAGEN INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q1 2022

As of 31 Mar 2022, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,090,221 shares. The largest 10 holders included COWEN AND COMPANY, LLC, Stonepine Capital Management, LLC, WASATCH ADVISORS INC, RTW INVESTMENTS, LP, BlackRock Inc., VANGUARD GROUP INC, MORGAN STANLEY, SILVERCREST ASSET MANAGEMENT GROUP LLC, PLATINUM INVESTMENT MANAGEMENT LTD, and PERKINS CAPITAL MANAGEMENT INC. This page lists 53 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.